MTU Library Catalogue

Syndetics cover image
Image from Syndetics

Psychotropic drug handbook / Paul J. Perry ... [et al.].

Contributor(s): Perry, Paul J | Perry, Paul J. Psychotropic drug handbook.
Material type: materialTypeLabelBookPublisher: Philadelphia : Lippincott Williams & Wilkins, c2007Edition: 8th ed.Description: xiv, 719 p. : ill. ; 22 cm.Content type: text Media type: unmediated Carrier type: volumeISBN: 0781762731; 9780781762731.Subject(s): Psychotropic drugs -- Handbooks, manuals, etc | Psychotropic Drugs -- Handbooks | Pharmacology | Pharmacy / dispensing | Health and WellbeingDDC classification: 615.788 PSY
Contents:
Antipsychotics -- Antidepressants -- Mood stabilizers -- Antianxiety agents (anxiolytics) -- Hypnotics -- Psychotropic drug treatment of alcohol and drug dependence -- Drug interactions -- Management of acute drug withdrawal -- Electroconvulsive therapy -- Pharmacotherapy of childhood and adolescent psychiatric disorders -- Geriatrics.
Summary: This succinct handbook provides students and practitioners with clinically relevant psychotropic drug information. It provides detailed, well-referenced, evidence-based information on a wide range of psychotropic drugs, including mood stabilizers, antidepressants, and antianxiety agents.
Holdings
Item type Current library Call number Copy number Status Barcode
General lending MTU Kerry North Campus Library First Floor Main 615.788 PSY (Browse shelf(Opens below)) 7 Available 38888000562318
General lending MTU Kerry North Campus Library First Floor Main 615.788 PSY (Browse shelf(Opens below)) 2 Available 38888000499263
General lending MTU Kerry North Campus Library First Floor Main 615.788 PSY (Browse shelf(Opens below)) 4 Available 38888000499248
Total holds: 0

Enhanced descriptions from Syndetics:

This succinct handbook provides students and practitioners with clinically relevant psychotropic drug information. The Eighth Edition is designed as a reference text that also teaches by delivering informative narrative text under standard headlines with references. Its focus goes beyond drug information to cover pharmacotherapy applications.



The book provides detailed, well-referenced, evidence-based information on a wide range of psychotropic drugs, including mood stabilizers, antidepressants, and antianxiety agents. This edition has new chapters on pediatric and geriatric psychopharmacotherapy; new content on antipsychotics, hypnotics, medications used in treating alcoholism and substance dependence, and electroconvulsive therapy; and new algorithms, appendices, and tables.

Rev. ed. of: Psychotropic drug handbook / Paul J. Perry, Bruce Alexander, Barry I. Liskow. 7th ed. c1997.

Includes bibliographical references and index.

Antipsychotics -- Antidepressants -- Mood stabilizers -- Antianxiety agents (anxiolytics) -- Hypnotics -- Psychotropic drug treatment of alcohol and drug dependence -- Drug interactions -- Management of acute drug withdrawal -- Electroconvulsive therapy -- Pharmacotherapy of childhood and adolescent psychiatric disorders -- Geriatrics.

This succinct handbook provides students and practitioners with clinically relevant psychotropic drug information. It provides detailed, well-referenced, evidence-based information on a wide range of psychotropic drugs, including mood stabilizers, antidepressants, and antianxiety agents.

Table of contents provided by Syndetics

  • Chapter 1 Antipsychotics (p. 1)
  • Second-Generation Antipsychotics (p. 6)
  • First-Generation Antipsychotics (p. 55)
  • References (p. 116)
  • Chapter 2 Antidepressants (p. 140)
  • Selective Serotonin Reuptake Inhibitors (p. 142)
  • Third-Generation Antidepressants (p. 166)
  • Tricyclic Antidepressants (p. 182)
  • Monoamine Oxidase Inhibitors (p. 199)
  • Benzodiazepines (p. 210)
  • CNS Stimulants (p. 211)
  • References (p. 212)
  • Chapter 3 Mood Stabilizers (p. 226)
  • Lithium (p. 227)
  • Valproate (p. 256)
  • Carbamazepine (p. 265)
  • Lamotrigine (p. 277)
  • Miscellaneous Treatments (p. 282)
  • Benzodiazepines (p. 283)
  • Clonidine (p. 283)
  • Gabapentin (p. 284)
  • Omega-3 Fatty Acids (p. 284)
  • Oxcarbazepine (p. 285)
  • Topiramate (p. 285)
  • Verapamil (p. 285)
  • References (p. 286)
  • Chapter 4 Antianxiety Agents (Anxiolytics) (p. 296)
  • Benzodiazepines (p. 296)
  • Antidepressants (p. 312)
  • [beta]-Adrenergic Blocking Drugs (p. 323)
  • Buspirone (p. 329)
  • Miscellaneous Agents (p. 334)
  • References (p. 337)
  • Chapter 5 Hypnotics (p. 352)
  • Definition and Evaluation of Insomnia (p. 352)
  • Nonpharmacologic Treatment of Insomnia (p. 356)
  • Pharmacologic Treatment of Insomnia (p. 357)
  • Benzodiazepine Receptor Agonists (p. 360)
  • Non-Benzodiazepine Receptor Agonists (p. 376)
  • Rational Prescribing of Hypnotics for Insomnia (p. 382)
  • Dietary Supplements for Treatment of Insomnia (p. 383)
  • Valerian (p. 383)
  • Melatonin (p. 385)
  • Tryptophan (p. 388)
  • Rational Prescribing of Dietary Supplements for Insomnia (p. 389)
  • Narcotherapy (p. 389)
  • References (p. 394)
  • Chapter 6 Psychotropic Drug Treatment of Alcohol and Drug Dependence (p. 404)
  • Disulfiram (p. 404)
  • Naltrexone (p. 414)
  • Acamprosate (p. 421)
  • Methadone and L-[alpha]-Acetyl Methadol (p. 424)
  • Buprenorphine (p. 428)
  • Promising Drugs for Treatment of Substance Dependence (p. 432)
  • References (p. 433)
  • Chapter 7 Drug Interactions (p. 440)
  • Types of Drug Interactions (p. 441)
  • Opportunities for Drug Interactions (p. 442)
  • Evidence for Drug Interactions (p. 448)
  • Explanations for Minimal Expression of Adverse Drug Interactions (p. 451)
  • References (p. 452)
  • Chapter 8 Management of Acute Drug Withdrawal (p. 454)
  • Ethanol Withdrawal (p. 454)
  • Anxiolytic-Hypnotic Withdrawal (p. 465)
  • Opiate Withdrawal (p. 481)
  • Nicotine Withdrawal (p. 491)
  • Central Nervous System Stimulant Withdrawal (p. 496)
  • References (p. 499)
  • Chapter 9 Electroconvulsive Therapy (p. 506)
  • Indications (p. 506)
  • Efficacy (p. 507)
  • Mechanism of Action (p. 512)
  • Treatment-Related Variables (p. 514)
  • Adverse Effects (p. 520)
  • Devices Used in ECT (p. 526)
  • Method of Administration (p. 526)
  • Medications Used in ECT (p. 532)
  • Rational Prescribing (p. 535)
  • References (p. 536)
  • Chapter 10 Pharmacotherapy of Childhood and Adolescent Psychiatric Disorders (p. 548)
  • Psychostimulants (p. 548)
  • Antidepressants (p. 560)
  • Antipsychotics (p. 571)
  • Mood Stabilizers (p. 576)
  • [alpha subscript 2]-Adrenergic Agonists (p. 578)
  • Anxiolytics (p. 581)
  • References (p. 583)
  • Chapter 11 Geriatrics (p. 591)
  • Introduction (p. 591)
  • Challenges and Guidelines of Psychotropic Drug Prescribing to the Geropsychiatric Patient (p. 595)
  • Pharmacokinetic and Dynamic Changes Occurring with Normal Aging (p. 596)
  • Mental Disorders and Other Treatable Conditions in the Elderly (p. 600)
  • Dementia (p. 602)
  • Overview of Drugs Used for the Treatment of Dementia (p. 602)
  • Acetylcholinesterase Inhibitors (p. 606)
  • NMDA Antagonist: Memantine (p. 609)
  • Depression (p. 610)
  • Nonpharmacologic Treatment (p. 610)
  • Pharmacotherapy of Depression in AD (p. 611)
  • Pharmacotherapy of Late-Life Depression (p. 612)
  • Pharmacotherapy of Depression with Medical Illness (p. 614)
  • Anxiety, Agitation, and Behavioral Problems (p. 615)
  • Sleep Problems (p. 617)
  • Summary (p. 618)
  • References (p. 618)
  • Appendix A Psychotropic Drug Product List (p. 625)
  • Appendix B Pregnancy Risk and Lactation Categories (p. 643)
  • Appendix C Psychotropic Drug Pharmacokinetic Parameters (p. 647)
  • Appendix D Psychotropic Drug Interactions (p. 657)
  • Index (p. 677)